Skip to main content
. 2020 Jul 22;8(3):532–544. doi: 10.1016/j.esxm.2020.06.004

Table 1.

Characteristics of participants (n = 192)

Characteristic Mean ± SD or count (%)
Sociodemographic
 Age (years) 35.7 ± 7.3
 Current marital status (n = 191)
 Single 21 (11.0)
 Married or registered partnership 110 (57.6)
 Committed relationship (cohabiting/LAT) 57 (29.8)
 Divorced 3 (1.6)
 Highest level of education (n = 192)
 Primary education 1 (0.5)
 Secondary education 32 (16.7)
 Secondary vocational education 74 (38.5)
 Higher education 85 (44.3)
 Currently working (n = 191)
 Yes 145 (75.9)
 No 46 (24.1)
 Not employed 7 (15.2)
 Unable to work due to health complaints 28 (60.9)
 Stay at home spouse or partner 11 (23.9)
Diagnostic
 Age at first symptoms (years) (n = 191) 24.3 ± 9.0
 Age at diagnosis (years) (n = 191) 30.9 ± 7.5
 Delay in diagnosis (years) (n = 192) 6.7 ± 7.6
 Period since diagnosis (years) (n = 192) 4.8 ± 5.2
 Center of recruitment (n = 192)
 Hospital A (academic) 68 (35.4)
 Hospital B 45 (23.4)
 Hospital C 37 (19.3)
 Hospital D (academic) 6 (3.1)
 Hospital E 5 (2.6)
 Hospital F 31 (16.1)
 Hospital G 0
Gynecological and obstetric
 Age at menarche (years) (n = 191) 12.8 ± 1.4
 Menstrual cycle (n = 192)
 Yes 156 (81.3)
 No 36 (18.8)
 Duration of menses in women with cycle (days) (n = 148) 6.4 ± 3.2
 History of pregnancy (n = 192)
 Yes 111 (57.8)
 No 81 (42.2)
 Parity (n = 192)
 Parous 91 (47.4)
 Nulliparous 101 (52.6)
 History of fertility treatment (n = 192)
 Yes 75 (39.1)
 No 117 (60.9)
 Pregnancy wish (n = 191)
 Yes 109 (57.1)
 No 82 (42.9)
 Intercourse in last 3 months (n = 192)
 Yes 166 (86.5)
 No 26 (13.5)
Endometriosis-associated symptoms
 Dysmenorrhea (women with menstrual cycle, n = 156)
 Yes 154 (98.7)
 No 2 (1.3)
 Severity 7.5 ± 2.0
 Frequency (days/cycle) 5.6 ± 4.9
 Abdominal pain between menstrual periods (n = 156)
 Yes 138 (88.5)
 No 18 (11.5)
 Severity 4.7 ± 2.3
 Frequency (days/cycle) 10.0 ± 8.7
 Abdominal pain (women without menstrual cycle, n = 36)
 Yes 31 (86.1)
 No 5 (13.9)
 Severity 5.0 ± 2.8
 Frequency (days/month) 14.4 ± 10.8
 Dyspareunia (intercourse in last 3 months, n = 166)
 Yes 119 (71.7)
 No 47 (28.3)
 Severity 5.3 ± 1.9
 Frequency (n = 119)
 Rarely 3 (2.5)
 Sometimes 27 (22.7)
 Regularly 47 (39.5)
 Often 20 (16.8)
 Always 22 (18.5)
 Dyschezia (n = 192)
 Yes 156 (81.3)
 No 36 (18.8)
 Severity 5.2 ± 2.3
 Frequency (n = 156)
 Rarely 5 (3.2)
 Sometimes 34 (21.8)
 Regularly 46 (29.5)
 Often 24 (15.4)
 Always 21 (13.5)
 Cyclical 26 (16.7)
 Dysuria (in total population, n = 192)
 Yes 76 (39.6)
 No 116 (60.4)
 Severity 4.6 ± 2.4
 Frequency (n = 76)
 Rarely 9 (11.8)
 Sometimes 26 (34.2)
 Regularly 28 (36.8)
 Often 11 (14.5)
 Always 2 (2.6)
Treatment
 First ever received treatment (n = 192)
 No treatment received yet 11 (5.7)
 Hormonal therapy 78 (40.6)
 Surgical therapy 88 (45.8)
 Hormonal and surgical therapy 15 (7.8)
 Currently using hormonal therapy (n = 191)
 Yes 129 (67.5)
 Progestogens only or in combination with estrogens 84 (65.1)
 GnRH analogues 45 (34.9)
 No 62 (32.5)
 Endometriosis surgery in medical history (n = 192)
 Yes 127 (66.1)
 No 65 (33.9)
 Other surgery in medical history (n = 191)
 Yes 131 (68.6)
 No 60 (31.4)
 Pain medication use (n = 191)
 Yes 155 (81.2)
 PCM 120 (77.4)
 NSAID 107 (69.9)
 Opiod 21 (13.7)
 No 36 (18.8)
EHP-30
 HRQoL score (n = 185) 41.8 ± 22.8
45.6 [37.1]
 SQoL score (n = 192) 47.5 ± 29.6
50.0 [48.8]

EHP-30 = Endometriosis Health Profile-30; GnRH = gonadotropin releasing hormone; HRQoL = health-related quality of life; LAT = living apart together; NSAID = non-steroidal anti-inflammatory drugs; PCM = paracetamol; SQoL = sexual quality of life.

Characteristics are depicted as count with percentage (%) or mean with SD.